Evidence map›Paper›PMID 42138325›Full record

ArticleChembiochem : a European journal of chemical biology2026

Biosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin-Like Lasso Peptide.

Tiziana Svenningsen, Aske Merrild, Fang Wang, Frederikke D Hansen, Toby G Johnson, Reina Iwase, Thibault Viennet, Morten K Larsen, A James Link, Thomas Tørring

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tiziana SvenningsenDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.
Aske MerrildDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.
Fang WangDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.
Frederikke D HansenDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.
Toby G JohnsonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.
Reina IwaseDepartment of Chemistry, Aarhus University, Aarhus, Denmark.
Thibault ViennetDepartment of Chemistry, Aarhus University, Aarhus, Denmark.
Morten K LarsenDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.
A James LinkDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.ORCID https://orcid.org/0000-0001-5066-9691
Thomas TørringDepartment of Biological & Chemical Engineering, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-5257-2121

Funding

Carlsbergfondet CF22-1239Danmarks Frie Forskningsfond 4251-00032BLindemann TrustNovo Nordisk Fonden NNF220C0075797Omenn-Darling Bioengineering Insitute
6 · The paper itself

Abstract

Lasso peptides are structurally unique natural products endowed with high thermal and proteolytic stability, making them attractive as scaffolds for drug discovery. Recently, a new class of lasso peptides containing a second macrocycle, formed between a lysine sidechain and the C-terminus, was discovered, resulting in an even more compact architecture. Here, we report the first NMR structure of the class V lasso peptide, gelatinamin A. Using heterologous expression of the gelatinamin biosynthetic gene cluster (BGC) in Bacillus subtilis, we delineated the biosynthetic pathway through targeted gene deletions. We expressed and characterized the predicted transpeptidase, GelP, that catalyzes the formation of an isopeptide bond between Lys2 and the C-terminus and mediates the reversible conversion of gelatinamin B to gelatinamin A. In addition, we characterize GelT, an N-acetyltransferase that inactivates lasso peptide antimicrobial activity by acetylating a key lysine residue. Furthermore, we demonstrate that gelatinamin is highly potent against several important pathogens and that the activity is strongly bicarbonate-dependent. Finally, we propose a complete biosynthetic pathway for gelatinamin. The structural insight of gelatinamin A and the functional characterization of GelP provide the foundation for future discovery of class V lasso peptides and for engineering transpeptidases to modify other lasso peptide scaffolds.

Indexed as

Anti-Bacterial AgentsPeptidesAmino Acid SequenceBacillus subtilisMicrobial Sensitivity TestsMultigene FamilyAnti-Bacterial AgentsPeptidesantibioticsheterologous expressionin vitrolasso peptidesRiPPs

Identifiers

PMID42138325
PMCPMC13178200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.